Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
2009
3.3K+
LTM Revenue $100M
LTM EBITDA $70.2M
$5.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Atlas Arteria has a last 12-month revenue of $100M and a last 12-month EBITDA of $70.2M.
In the most recent fiscal year, Atlas Arteria achieved revenue of $91.1M and an EBITDA of $279M.
Atlas Arteria expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Atlas Arteria valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $83.7M | $91.1M | XXX | XXX | XXX |
Gross Profit | $40.8M | $77.3M | XXX | XXX | XXX |
Gross Margin | 49% | 85% | XXX | XXX | XXX |
EBITDA | $268M | $279M | XXX | XXX | XXX |
EBITDA Margin | 320% | 306% | XXX | XXX | XXX |
Net Profit | $168M | $203M | XXX | XXX | XXX |
Net Margin | 200% | 223% | XXX | XXX | XXX |
Net Debt | $901M | $874M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Atlas Arteria's stock price is AUD 5 (or $3).
Atlas Arteria has current market cap of AUD 7.1B (or $4.4B), and EV of AUD 8.6B (or $5.4B).
See Atlas Arteria trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$5.4B | $4.4B | XXX | XXX | XXX | XXX | $0.13 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Atlas Arteria has market cap of $4.4B and EV of $5.4B.
Atlas Arteria's trades at 53.6x LTM EV/Revenue multiple, and 76.7x LTM EBITDA.
Analysts estimate Atlas Arteria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Atlas Arteria and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $5.4B | XXX | XXX | XXX |
EV/Revenue | 59.1x | XXX | XXX | XXX |
EV/EBITDA | 19.3x | XXX | XXX | XXX |
P/E | 21.0x | XXX | XXX | XXX |
P/E/Growth | 1.4x | XXX | XXX | XXX |
EV/FCF | 93.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAtlas Arteria's NTM/LTM revenue growth is 23%
Atlas Arteria's revenue per employee for the last fiscal year averaged $28K, while opex per employee averaged $28K for the same period.
Over next 12 months, Atlas Arteria's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Atlas Arteria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Atlas Arteria and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 9% | XXX | XXX | XXX | XXX |
EBITDA Margin | 306% | XXX | XXX | XXX | XXX |
EBITDA Growth | 4% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 329% | XXX | XXX | XXX | XXX |
Revenue per Employee | $28K | XXX | XXX | XXX | XXX |
Opex per Employee | $28K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 24% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 101% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ferrovial | XXX | XXX | XXX | XXX | XXX | XXX |
Smart Parking | XXX | XXX | XXX | XXX | XXX | XXX |
Transurban Group | XXX | XXX | XXX | XXX | XXX | XXX |
Ventia | XXX | XXX | XXX | XXX | XXX | XXX |
IRB Infrastructure Developers | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Atlas Arteria acquired XXX companies to date.
Last acquisition by Atlas Arteria was XXXXXXXX, XXXXX XXXXX XXXXXX . Atlas Arteria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Atlas Arteria founded? | Atlas Arteria was founded in 2009. |
Where is Atlas Arteria headquartered? | Atlas Arteria is headquartered in Australia. |
How many employees does Atlas Arteria have? | As of today, Atlas Arteria has 3.3K+ employees. |
Who is the CEO of Atlas Arteria? | Atlas Arteria's CEO is Mr. Hugh Wehby. |
Is Atlas Arteria publicy listed? | Yes, Atlas Arteria is a public company listed on ASX. |
What is the stock symbol of Atlas Arteria? | Atlas Arteria trades under ALX ticker. |
When did Atlas Arteria go public? | Atlas Arteria went public in 2010. |
Who are competitors of Atlas Arteria? | Similar companies to Atlas Arteria include e.g. Ferrovial, Smart Parking, Transurban Group, Ventia. |
What is the current market cap of Atlas Arteria? | Atlas Arteria's current market cap is $4.4B |
What is the current revenue of Atlas Arteria? | Atlas Arteria's last 12-month revenue is $100M. |
What is the current EBITDA of Atlas Arteria? | Atlas Arteria's last 12-month EBITDA is $70.2M. |
What is the current EV/Revenue multiple of Atlas Arteria? | Current revenue multiple of Atlas Arteria is 53.6x. |
What is the current EV/EBITDA multiple of Atlas Arteria? | Current EBITDA multiple of Atlas Arteria is 76.7x. |
What is the current revenue growth of Atlas Arteria? | Atlas Arteria revenue growth between 2023 and 2024 was 9%. |
Is Atlas Arteria profitable? | Yes, Atlas Arteria is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.